P89 IL-28 as potential therapeutic target for LN
Main Authors: | Andreas Schwarting, Tamara Möckel, Myriam Meineck, Julia Weinmann-Menke, Andreas Kommer, Sebastian Linsel, Sabrina Saurin, Andrea Pautz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-03-01
|
Series: | Lupus Science and Medicine |
Similar Items
-
P103 14-Deoxy-14-methyloxacyclododecindione: a new therapeutic approach of SLE?
by: Myriam Meineck, et al.
Published: (2024-03-01) -
Drug Candidates for Autoimmune Diseases
by: Sabrina Saurin, et al.
Published: (2022-04-01) -
Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease Initiation
by: Paul Marczynski, et al.
Published: (2021-02-01) -
The macrocyclic lactone oxacyclododecindione reduces fibrosis progression
by: Sabrina Saurin, et al.
Published: (2023-06-01) -
Constitutive knockout of interleukin-6 ameliorates memory deficits and entorhinal astrocytosis in the MRL/lpr mouse model of neuropsychiatric lupus
by: Joshua Reynolds, et al.
Published: (2024-04-01)